Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome
This study has been completed.
Study NCT00208026   Information provided by Children's Hospital of Philadelphia
First Received: September 13, 2005   Last Updated: May 9, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Netherton Syndrome
Additional conditions recognized in this trial
Syndrome
More general conditions related to this trial
Disease
Pathologic Processes
Interventions listed in this trial
Elidel (Pimecrolimus) 1% Cream
Additional drug interventions recognized in this trial
Pimecrolimus
Tacrolimus
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Dermatologic Agents
Immunologic Factors
Immunosuppressive Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Children's Hospital of Philadelphia
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services